STAT News

STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class

The FDA approved a treatment for advanced multiple myeloma made by Bristol Myers Squibb, marking the debut of a new class of drugs for the blood cancer.

作者 STAT News

1 分钟阅读
STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class
STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class

有活动行业的新闻要分享吗?

提交新闻稿或信息,触达数千名活动行业专业人士。

联系我们→

更多Health Tech相关内容

相关洞察